title: F-18 FDG PET/CT as a valuable imaging tool for assessing treatment efficacy in inflammatory and infectious diseases.
authors.affiliation: Service de Biophysique et de Médecine Nucléaire, Hôpitaux Universitaires de Strasbourg, Strasbourg, France. alessio.imperiale@chru-strasbourg.fr
authors.forename: Alessio
authors.initials: A
authors.lastname: Imperiale
authors.forename: Laure
authors.initials: L
authors.lastname: Federici
authors.forename: Nicolas
authors.initials: N
authors.lastname: Lefebvre
authors.forename: Jean-Jacques
authors.initials: JJ
authors.lastname: Braun
authors.forename: Francis
authors.initials: F
authors.lastname: Pfumio
authors.forename: Romain
authors.initials: R
authors.lastname: Kessler
authors.forename: Yves
authors.initials: Y
authors.lastname: Hansmann
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Andres
authors.forename: André
authors.initials: A
authors.lastname: Constantinesco
mesh_terms: D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D007239:Infections / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000628:therapy*; D007249:Inflammation / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D049268:Positron-Emission Tomography; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D019788:Fluorodeoxyglucose F18